ACUTA CAPITAL PARTNERS, LLC Hedge Fund

Location: Redwood City, CA

CIK: 0001582844 · Show all filings

Period: Q4 2018 (← Previous) (Next →)

Filing Date: Feb 14, 2019

Total Value: $131M (100.0% shares, 0.0% debt)

Holdings (21)

IOVA IOVANCE BIOTHERAPEUTICS INC 20.4%
Value $26.72M Shares 3,019,201 Est. Cost $7.92 Unrealized +21.8%
ASSEMBLY BIOSCIENCES INC 12.4%
Value $16.25M Shares 718,500 Est. Cost $16.39 Unrealized
KADMON HLDGS INC 12.0%
Value $15.68M Shares 7,538,000 Est. Cost $3.69 Unrealized
CAS MED SYS INC 6.4%
Value $8.422M Shares 5,263,508 Est. Cost $1.45 Unrealized
XBI SPDR SERIES TRUST 5.5%
Value $7.175M Shares 100,000 Est. Cost Unrealized
BIOHAVEN PHARMACTL HLDG CO L 5.3%
Value $6.934M Shares 187,500 Est. Cost $38.77 Unrealized
AMARIN CORP PLC 4.5%
Value $5.954M Shares 437,500 Est. Cost $14.04 Unrealized
IMMUNOMEDICS INC 4.4%
Value $5.708M Shares 400,000 Est. Cost $12.30 Unrealized
IMMUNOMEDICS INC 4.4%
Value $5.708M Shares 400,000 Est. Cost $12.30 Unrealized
VCYT VERACYTE INC 4.2%
Value $5.567M Shares 442,500 Est. Cost $7.25 Unrealized +63.2%
IRIX IRIDEX CORP 4.2%
Value $5.52M Shares 1,174,500 Est. Cost $11.40 Unrealized -56.4%
ARGX ARGENX SE 3.9%
Value $5.092M Shares 53,000 Est. Cost $48.57 Unrealized
KALV KALVISTA PHARMACEUTICALS INC 2.6%
Value $3.417M Shares 173,000 Est. Cost $15.20 Unrealized +32.3%
XENE XENON PHARMACEUTICALS INC 2.6%
Value $3.392M Shares 537,500 Est. Cost $6.81 Unrealized +30.5%
ACER THERAPEUTICS INC 2.2%
Value $2.877M Shares 143,000 Est. Cost $21.25 Unrealized
CHEMBIO DIAGNOSTICS INC 1.7%
Value $2.191M Shares 387,167 Est. Cost $7.05 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 1.5%
Value $1.99M Shares 53,800 Est. Cost $38.77 Unrealized
VRAYQ VIEWRAY INC 1.4%
Value $1.891M Shares 311,500 Est. Cost $6.35 Unrealized +18.0%
SUTRO BIOPHARMA INC 0.3%
Value $410K Shares 45,500 Est. Cost $9.01 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 0.2%
Value $202K Shares 25,000 Est. Cost $7.78 Unrealized 0.0%
OUTLOOK THERAPEUTICS INC 0.0%
Value $15,000 Shares 29,082 Est. Cost $0.52 Unrealized